Articles with public access mandates - Pedro Rosa-NetoLearn more
OverallCIHRFRQSNIHMRCEuropean CommissionSwedish Research CouncilDoDNSERCNIHRWellcomeAlzheimers's UKNSFCZonMwKnut and Alice Wallenberg FoundationGovernment of SpainBrain Research, UKDFGGovernment of ItalyBMBFNMRCNWOANRMichael J Fox FoundationCanada First Research Excellence FundDOEMarianne and Marcus Wallenberg FoundationGenome CanadaBanking Foundation "la Caixa"SNSFNHMRCHSFINSERMDSTNSFVAFWOHelmholtzEPSRCESRCUSEDARCDFFAcademy of FinlandFCTFormasBBSRCMotor Neurone Disease Association, UKParkinson's UKInnovation Fund DenmarkFRQNTFRQSCSCFASAPParkinson's Foundation, USAAXA Research Fund, FranceCPRIT
Not available anywhere: 34
Astrocyte biomarkers in Alzheimer’s disease
SF Carter, K Herholz, P Rosa-Neto, L Pellerin, A Nordberg, ER Zimmer
Trends in molecular medicine 25 (2), 77-95, 2019
Mandates: Swedish Research Council, Agence Nationale de la Recherche
Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model
B Ongali, N Nicolakakis, XK Tong, T Aboulkassim, P Papadopoulos, ...
Neurobiology of disease 68, 126-136, 2014
Mandates: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
The effects of exercise on sleep quality in persons with Parkinson's disease: a systematic review with meta-analysis
J Cristini, M Weiss, B De Las Heras, A Medina-Rincon, A Dagher, ...
Sleep medicine reviews 55, 101384, 2021
Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé …
Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issues
A Leuzy, ER Zimmer, K Heurling, P Rosa-Neto, S Gauthier
Amyloid 21 (3), 143-148, 2014
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Test‐retest stability of cerebral mGluR5 quantification using [11C]ABP688 and positron emission tomography in rats
D Elmenhorst, A Aliaga, A Bauer, P Rosa‐Neto
Synapse 66 (6), 552-560, 2012
Mandates: Fonds de recherche du Québec - Santé
Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer’s disease
J Therriault, TA Pascoal, M Savard, S Mathotaarachchi, AL Benedet, ...
Science Translational Medicine 14 (659), eabc8693, 2022
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy
J Lam, JM DuBois, J Rowley, KA González‐Otárula, JP Soucy, ...
Annals of Neurology 85 (2), 218-228, 2019
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases
JJ Bailey, L Kaiser, S Lindner, M Wüst, A Thiel, JP Soucy, P Rosa-Neto, ...
ACS chemical neuroscience 10 (6), 2697-2702, 2019
Mandates: Natural Sciences and Engineering Research Council of Canada
Normal cognition in Parkinson's disease may involve hippocampal cholinergic compensation: An exploratory PET imaging study with [18F]-FEOBV
C Legault-Denis, M Aghourian, JP Soucy, P Rosa-Neto, A Dagher, ...
Parkinsonism & Related Disorders 91, 162-166, 2021
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis
G Carello-Collar, B Bellaver, PCL Ferreira, JP Ferrari-Souza, VG Ramos, ...
Molecular Psychiatry 28 (12), 5025-5036, 2023
Mandates: Fonds de recherche du Québec - Santé
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
J Therriault, SE Schindler, G Salvadó, TA Pascoal, AL Benedet, ...
Nature Reviews Neurology 20 (4), 232-244, 2024
Mandates: Fonds de recherche du Québec - Santé
Dynamic 1H‐MRS for detection of 13C‐labeled glucose metabolism in the human brain at 3T
M Dehghani, S Zhang, C Kumaragamage, P Rosa‐Neto, J Near
Magnetic resonance in medicine 84 (3), 1140-1151, 2020
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Frontal variant of Alzheimer disease differentiated from frontotemporal dementia using in vivo amyloid and tau imaging
V Paquin, J Therriault, TA Pascoal, P Rosa-Neto, S Gauthier
Cognitive and Behavioral Neurology 33 (4), 288-293, 2020
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Nonamyloid PET biomarkers and Alzheimer's disease: current and future perspectives
LP Schilling, A Leuzy, ER Zimmer, S Gauthier, P Rosa-Neto
Future Neurology 9 (6), 597-613, 2014
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
The glutamatergic system in alzheimer’s disease: A systematic review with meta-analysis
C Soares, LU Da Ros, LS Machado, A Rocha, G Lazzarotto, ...
Molecular Psychiatry, 1-13, 2024
Mandates: Fonds de recherche du Québec - Santé
Normative Values of Neuromelanin‐Sensitive MRI Signal in Older Adults Obtained Using a Turbo Spin Echo Sequence
R Al Haddad, M Chamoun, CL Tardif, S Guimond, G Horga, P Rosa‐Neto, ...
Journal of Magnetic Resonance Imaging 58 (1), 294-300, 2023
Mandates: Fonds de recherche du Québec - Santé, Natural Sciences and Engineering …
In vivo hippocampal cornu ammonis 1–3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes
J Lam, JM DuBois, J Rowley, OG Rousset, KA González‐Otárula, ...
Epilepsia 62 (7), 1559-1568, 2021
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Clinical correlates of the PET-based Braak staging framework in Alzheimer’s disease
AC Macedo, D Durço, C Tissot, J Therriault, AO Vilela de Faria, E Aumont, ...
The Journal of Prevention of Alzheimer's Disease 11 (2), 414-421, 2024
Mandates: Fonds de recherche du Québec - Santé
Neuromelanin-sensitive MRI as an index of norepinephrine system integrity in healthy aging, mild cognitive impairment, and Alzheimer’s disease
C Cassidy, S Celebi, M Savard, M Chamoun, CL Tardif, P Rosa-Neto
Biological Psychiatry 87 (9), S424-S425, 2020
Mandates: Canadian Institutes of Health Research
Towards the PET radiotracer for p75 neurotrophin receptor:[11C] LM11A-24 shows biological activity in vitro, but unfavorable ex vivo and in vivo profile
J Gibon, MS Kang, A Aliaga, B Sharif, P Rosa-Neto, P Séguéla, PA Barker, ...
Bioorganic & Medicinal Chemistry 24 (19), 4759-4765, 2016
Mandates: Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program